{
    "nctId": "NCT04267315",
    "briefTitle": "Trigger Point Injections for Post-Mastectomy Pain Syndrome",
    "officialTitle": "Trigger Point Injections for Post-Mastectomy Pain Syndrome: A Double-Blind Randomized Controlled Trial With Intention-to-Treat Analysis",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Post-mastectomy Pain Syndrome, Myofascial Pain Syndrome, Trigger Point Pain, Myofascial, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 72,
    "primaryOutcomeMeasure": "Visual Numeric Scale (VNS) for pain in 3 months",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer patients.\n* PMPS diagnosis, as per Wisotzky et col.\n\n  * Pain \\> 3 months over breast, chest wall or shoulder ipsilateral to surgery.\n* Pain Visual analog Scale (VAS) \u22654.\n* At least one active trigger point in the following muscles: pectoralis major, superior trapezius, serratus anterior, levator scapularis, latissimus dorsi, infraspinatus\n\nExclusion Criteria:\n\n* Current radiation therapy or time since completion \\< 3months.\n* Allergy to lidocaine or other local anesthetics\n* Active infection over injection sites\n* Unavailability to be at the hospital during study intervention.",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}